Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

MGC PHARMACEUTICALS LTD

INVESTOR PRESENTATION - MGC PHARMACEUTICALS LTD

ASX:MXC

MGC PHARMACEUTICALS LTD

Health Care

MGC Pharmaceuticals Limited (ASX:MXC, also listed on US OTCQB) is a European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally, with a core strategy of "Seed to Pharma" implementation. The company has operations spanning Europe and Australia.

Read more

Market Cap

34.46m

Price at Close

$0.021

4w avg. Volume

3.33m

4w avg. Turnover

$76.64k

Announcements
announcementt+2 movementdate
  • Annual Report 2020

    Periodic Reports

  • -

    28 Oct 2020

-

28 Oct 2020
  • MGC Pharma AGM Information and Webinar

    Notice Of Meeting

  • -4.55%

    27 Oct 2020

-4.55%

27 Oct 2020
  • September Quarterly Activity and Cashflow Report

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    26 Oct 2020

0.00%

26 Oct 2020
  • Unmarketable Parcel Share Sale Update

    Issued Capital

  • 0.00%

    26 Oct 2020

0.00%

26 Oct 2020
  • MGC PHARMA DELIVERS RECORD CONSECUTIVE WEEKLY SALES GROWTH

    Progress Report · Market sensitive

  • +4.35%

    19 Oct 2020

+4.35%

19 Oct 2020
  • ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT

    Progress Report · Market sensitive

  • -4.17%

    14 Oct 2020

-4.17%

14 Oct 2020
  • FIRST HIGH THC PRODUCTS SHIPPED DIRECT TO BRAZIL PATIENTS

    Progress Report · Market sensitive

  • +4.35%

    11 Oct 2020

+4.35%

11 Oct 2020
  • MGC PHARMA LAUNCHES CANNEPIL APP

    Progress Report · Market sensitive

  • +4.55%

    06 Oct 2020

+4.55%

06 Oct 2020
  • Letter to Shareholders - Upcoming Annual General Meeting

    Other

  • -4.35%

    02 Oct 2020

-4.35%

02 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -4.35%

    02 Oct 2020

-4.35%

02 Oct 2020
Market Data

Current Price

$0.021

52WK HIGH

$0.042

52WK LOW

$0.015

1YR RETURN

-38.24%

1YR RETURN VS. SECTOR

-53.80%

90 DAY RETURN

0.00%

ASX RANK

1,225

/2,011

SECTOR RANK

21

/30

SHARES OUTSTANDING

1.64b
ASX:MXC

MGC PHARMACEUTICALS LTD

Health Care

MGC Pharmaceuticals Limited (ASX:MXC, also listed on US OTCQB) is a European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally, with a core strategy of "Seed to Pharma" implementation. The company has operations spanning Europe and Australia.

Read more

Market Cap

34.46m

Price at Close

$0.021

4w avg. Volume

3.33m

4w avg. Turnover

$76.64k

ASX:MXC is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.